Human cytomegalovirus (HCMV) is now recognized as a significant pathogen which can cause birth defects in congenitally infected infants, interstitial pneumonia in immunologically compromised individuals, or persist as a latent infection which can be reactivated at a later time. The overall aim of this project is to identify viral-cellular interactions which determine whether HCMV will productively infect a cell or remain latent. Two different cell systems will be utilized to reach this goal. To determine if lymphocytes can latently harbor HCMV, subpopulations of peripheral blood lymphocytes, separated by the fluorescence activated cell sorter, will be infected with laboratory strains and recent isolates. In parallel with the lymphocyte experiments, studies will examine events following HCMV infection of an established cell line of human teratocarcinoma cells. Both cell systems will be examined for persisitence of viral DNA, RNA, and proteins using Southern and Northern blotting techniques and immunofluorescence with viral protein specific monoclonal antibodies. Non-productively infected teratocarcinoma cells and lymphocytes will be examined for expression of viral genes to determine at what stage the block in replication occurs. Cellular processes such as transcript processing, accumulation, transport, and association with polysomes will also be studied as possible regulators of viral replication. These studies will consist of examination of nuclear cytoplasmic and polysome RNA, and in vitro run-off transcription of specific HCMV genes. Active and inactive HCMV genes from these cells will also be examined for DNaseI hypersensitivity and the degree of methylation. Correlation of results from non-productively infected lymphocytes and teratocarcinoma cells will enhance our knowledge of HCMV latency.
| Hancock, Meaghan H; Skalsky, Rebecca L (2018) Roles of Non-coding RNAs During Herpesvirus Infection. Curr Top Microbiol Immunol 419:243-280 |
| Hancock, Meaghan H; Nelson, Jay A (2017) Modulation of the NF?b Signalling Pathway by Human Cytomegalovirus. Virology (Hyderabad) 1: |
| Hancock, Meaghan H; Hook, Lauren M; Mitchell, Jennifer et al. (2017) Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-?B-Activating Factors through Direct Downregulation of IKK? and IKK?. MBio 8: |
| Caviness, Katie; Bughio, Farah; Crawford, Lindsey B et al. (2016) Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency. MBio 7:e01986 |
| Sylwester, Andrew; Nambiar, Kate Z; Caserta, Stefano et al. (2016) A new perspective of the structural complexity of HCMV-specific T-cell responses. Mech Ageing Dev 158:14-22 |
| Landais, Igor; Pelton, Chantel; Streblow, Daniel et al. (2015) Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NF?B Signaling Pathway. PLoS Pathog 11:e1004881 |
| Crawford, Lindsey B; Streblow, Daniel N; Hakki, Morgan et al. (2015) Humanized mouse models of human cytomegalovirus infection. Curr Opin Virol 13:86-92 |
| Hook, Lauren M; Landais, Igor; Hancock, Meaghan H et al. (2014) Techniques for characterizing cytomegalovirus-encoded miRNAs. Methods Mol Biol 1119:239-65 |
| Hook, Lauren; Hancock, Meaghan; Landais, Igor et al. (2014) Cytomegalovirus microRNAs. Curr Opin Virol 7:40-6 |
| Hakki, Morgan; Goldman, Devorah C; Streblow, Daniel N et al. (2014) HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors. Biol Blood Marrow Transplant 20:132-5 |
Showing the most recent 10 out of 81 publications
